Hemophilia B
RareBlood Disorders
Hemophilia B is treated with 6 medications in our database, including Hemgenix, REBINYN, Ixinity, HEMGENIX, PYQUVI, and 1 more. 4 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by CSL Behring, Novo Nordisk, Medexus, Genentech. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Hemophilia B treatment below.
What help exists for Hemophilia B
7
drugs indexed
5
with copay cards
5
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Hemophilia B
7 totalPYQUVI
deflazacort · Merz North America, Inc.
Alhemo
concizumab · Novo Nordisk
🎟💙Ixinity
coagulation factor IX (recombinant) · Medexus
🎟💙REBINYN
coagulation factor IX recombinant, GlycoPEGylated · Novo Nordisk
🎟💙Hemgenix
etranacogene dezaparvovec · CSL Behring
🎟💙HYMPAVZI
marstacimab-hncq · Pfizer
🎟💙Itovebi
Inavolisib · Genentech
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Hemophilia B drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
Grants for Hemophilia B patients
3 total · 0 openHemophilia B is a rare disease — more resources at UniteRare
Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.
Visit UniteRare →